State Policies Regulating Law Enforcement Access to Prescription Drug Monitoring Program Testosterone Prescription Data
Authors:
- 26 November 2024
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 332 (20) , 1754-1757
Abstract
This study identifies state policies authorizing law enforcement access to prescription drug monitoring program data and discusses the characteristics of those policies, particularly in states with laws banning gender-affirming care.Keywords
This publication has 4 references indexed in Scilit:
- Protecting Privacy of Pregnant and LGBTQ+ Research ParticipantsJAMA, 2024
- Analysis of Access to Prescription Data Management Programs Data for ResearchJAMA Network Open, 2022
- Mental Health Outcomes in Transgender and Nonbinary Youths Receiving Gender-Affirming CareJAMA Network Open, 2022
- Deploying Prescription Drug Monitoring to Address the Overdose CrisisIndiana Health Law Review, 2018